[Form 4] UiPath, Inc. Insider Trading Activity

Rhea-AI Filing Summary

UiPath CEO and Chairman Daniel Dines reported a significant insider transaction on June 24, 2025, selling 45,000 shares of Class A Common Stock at an average price of $12.4876 per share (ranging from $12.4150 to $12.5500). The transaction was executed through a pre-planned 10b5-1 trading plan.

Following the transaction, Dines maintains substantial holdings in UiPath:

• 24,918,585 shares held directly
• 5,733,376 shares held indirectly through Ice Vulcan Holding Limited
• 240,000 shares held indirectly through spouse

As a Director, CEO, Chairman, and 10% Owner, Dines maintains significant control over the company. The shares held through Ice Vulcan Holding Limited are controlled by Dines through a corporate structure where he retains sole voting and investment power.

Positive

• None.

Negative

• CEO Daniel Dines sold 45,000 shares at $12.49 per share (~$562K) through a pre-planned 10b5-1 trading plan, though he maintains significant holdings of over 30M shares directly and indirectly

Insights

Securities Transactions Analyst

CEO Daniel Dines sold 45,000 shares via planned 10b5-1 trading while maintaining substantial holdings of over 30 million shares.

This Form 4 filing discloses that Daniel Dines, UiPath's CEO, Chairman, and 10% owner, sold 45,000 shares of Class A Common Stock on June 24, 2025, at an average price of $12.4876 per share. The transaction was executed through a qualified Rule 10b5-1 selling plan, which was established in advance to allow insiders to sell shares according to predetermined parameters regardless of any material non-public information they may later possess.

Despite this sale, Dines maintains substantial ownership in UiPath, with 24,918,585 shares held directly and additional indirect holdings of 5,733,376 shares through Ice Vulcan Holding Limited (where he retains sole voting and investment power) and 240,000 shares held by his spouse. The total post-transaction holdings of approximately 30.9 million shares demonstrate Dines' continued significant equity stake in the company.

The sale represents only about 0.15% of Dines' total beneficial ownership, suggesting this is likely part of a routine diversification or liquidity strategy rather than a significant reduction in his position. The use of a 10b5-1 plan further supports this interpretation, as such plans are typically established for systematic, periodic selling rather than opportunistic transactions based on current company performance or outlook.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dines Daniel

(Last) (First) (Middle)

C/O UIPATH, INC., ONE VANDERBILT AVENUE

60TH FLOOR

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UiPath, Inc. [ PATH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and Chairman

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	06/24/2025		S		45,000(1)	D	$12.4876(2)	5,733,376	I	See Footnote(3)
Class A Common Stock								24,918,585	D
Class A Common Stock								240,000	I	by Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold in compliance with a qualified selling plan adopted by the Reporting Person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.

2. The range of prices for the transactions reported was from $12.4150 to $12.5500. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

3. The shares are held by Ice Vulcan Holding Limited. IceVulcan Investments Ltd. is the sole shareholder of Ice Vulcan Holding Limited, and Mr. Dines is the sole shareholder of IceVulcan Investments Ltd. Mr. Dines retains sole voting and investment power with respect to the shares of Class A Common Stock and Class B Common Stock held by Ice Vulcan Holding Limited.

Remarks:

	/s/ Brad Brubaker, Attorney-in-Fact	06/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many PATH shares did CEO Daniel Dines sell on June 24, 2025?

CEO Daniel Dines sold 45,000 shares of UiPath (PATH) Class A Common Stock at an average price of $12.4876 per share on June 24, 2025. The sales were executed through a Rule 10b5-1 trading plan.

What is Daniel Dines' total PATH stock ownership after the June 2025 transaction?

After the transaction, Daniel Dines beneficially owned: 24,918,585 shares directly, 5,733,376 shares indirectly through Ice Vulcan Holding Limited, and 240,000 shares indirectly through his spouse, for a total beneficial ownership of approximately 30.9 million shares.

What price range did PATH CEO sell his shares for in June 2025?

According to the Form 4 filing, the shares were sold at prices ranging from $12.4150 to $12.5500 per share, with a weighted average price of $12.4876.

What positions does Daniel Dines hold at PATH according to the Form 4?

According to the Form 4, Daniel Dines serves as CEO and Chairman of UiPath (PATH). He is also listed as a Director and a 10% Owner of the company.

Was PATH CEO Dines' stock sale part of a planned transaction?

Yes, the Form 4 indicates that the shares were sold in compliance with a qualified selling plan adopted pursuant to Rule 10b5-1, which is a pre-planned trading arrangement to avoid insider trading concerns.